Insider Transactions in Q4 2025 at Beam Therapeutics Inc. (BEAM)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2025
|
Sravan Kumar Emany Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,294
-7.87%
|
$169,938
$27.1 P/Share
|
|
Dec 31
2025
|
Amy Simon Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+13.91%
|
-
|
|
Dec 31
2025
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,254
-1.07%
|
$33,858
$27.1 P/Share
|
|
Oct 27
2025
|
Fmr LLC |
SELL
Open market or private sale
|
Indirect |
459
-97.04%
|
$11,934
$26.68 P/Share
|
|
Oct 06
2025
|
Fmr LLC |
SELL
Bona fide gift
|
Indirect |
1,232,434
-59.43%
|
-
|
|
Oct 02
2025
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.47%
|
$600,000
$24.63 P/Share
|
|
Oct 02
2025
|
John M. Evans CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+2.41%
|
$0
$0.67 P/Share
|
|
Oct 01
2025
|
Bethany J Cavanagh SVP, Finance and Treasurer |
SELL
Open market or private sale
|
Direct |
467
-1.05%
|
$11,208
$24.53 P/Share
|
|
Oct 01
2025
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
373
-0.32%
|
$8,952
$24.53 P/Share
|
|
Oct 01
2025
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.47%
|
$600,000
$24.51 P/Share
|
|
Oct 01
2025
|
John M. Evans CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+2.41%
|
$0
$0.67 P/Share
|